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Background:  Patients with acute Achilles tendon rupture (ATR) exhibit prolonged 
healing, high incidence of deep venous thrombosis (DVT) and a wide variation of 
functional outcome. This extensive discrepancy in outcome may be explained by a 
lack of knowledge of detrimental factors, and subsequent shortage of adequate 
interventions.  
Methods: A total of 111 patients (84 men, 16 women; mean age 40.3±8.4) with acute 
total ATR were prospectively assessed. At one year post-operatively a uniform 
outcome score, Achilles Combined Outcome Score (ACOS), was obtained by 
combining three validated, independent, outcome measures: Achilles tendon Total 
Rupture Score, heel-rise height test, and limb symmetry heel-rise height. Candidate 
predictors of ACOS included; treatment, sex, age, smoking, body mass index (BMI), 
time to surgery, physical activity level pre- and post-injury, symptoms, quality of life 
and DVT-incidence.  
Results: Three independent variables correlated significantly with the dichotomized 
outcome score ACOS, while the other factors demonstrated no correlation. Low age 
(40 or less=0; above 40=1) was the strongest independent predictor of developing a 
good outcome at one year after ATR (OR= 0.20, 95 % C.I. 0.08 – 0.51), followed by 
female gender (Man= 1; Woman= 2) (OR= 4.18, 95 % C.I. 1.01 – 17.24). Notably, 
patients without a DVT (No=0, Yes=1) during post-operative immobilization 
experienced a better outcome (OR= 0.31, 95 % C.I. 0.12 – 0.80).  
Conclusion: DVT during leg immobilization, aging and male gender are independent 
negative predictors of outcome in patients with acute ATR. Age and gender should 
be further studied as to pinpoint the underlying causes leading to poor outcome. To 
enhance the outcome after ATR the first clinical focus should be on DVT-prevention 
during immobilization, possibly by usage of mechanical compression therapy and 
early weight bearing and mobilization. 
Introduction 
Repair after acute Achilles tendon rupture (ATR) is a prolonged process, associated 
with major functional deficits and an unknown wide variation of outcome between 
patients (1-5). 
Current meta-analyses of the outcome after ATR have mainly focused on operative 
versus non-operative treatment, lately demonstrating no superiority of one over the 
other when early mobilization is applied. However, when it comes to other factors 
and variables affecting outcome of ATR there is currently a lack of knowledge. 
Recently one study investigated how patient characteristics affected outcome in male 
ATR patients (6). It was found that increased age was a strong predictor of reduced 
function (6). In an earlier paper a substantial impaired function at one year 
postoperatively ATR was demonstrated (7). Gender, pain, and physical functioning 
during rehabilitation seemed to be important factors for functional outcome. However, 
the under-representation of female ATR patients has made it difficult to investigate 
the importance of gender on outcome (7). 
The reason for the variability in outcome at least one year after ATR, however, is still 
unknown. Recently, a very high rate of deep venous thrombosis (DVT) 36-50%, 
irrespective of operative or non-operative treatment, has been demonstrated after 
ATR (8-10). Yet, whether common complications with DVT are associated with 
impaired outcome of ATR patients remains unclear.  
In the present study we hypothesized that DVT and gender as well as multiple 
variables including age, BMI, treatment, physical activity score and smoking would 
influence the outcome of ATR. The aim of this observational cohort study was to 
assess intrinsic and extrinsic factors that could predict the combined objective and 
subjective outcome as assessed with validated scores of lower limb function and 
patient-related outcome at one year after ATR. 
 
Patients and Methods 
Patients: The patients were included from a cohort of 150 patients with acute 
Achilles tendon rupture included in a prospective, randomized controlled trial (RCT) 
study (www.clinicaltrials.gov; trial number NCT01317160). The results on DVT 
incidence of the RCT have been previously described (11). A total number of 111 
patients were assessed at the one-year follow-up (Table 1). 
The inclusion criteria were (i): acute unilateral Achilles tendon rupture, operated on 
within 96 hours, (ii) age between 18 and 75 years. The exclusion criteria were 
identical as described in earlier published material (11). Two patients were 
withdrawn, one because of an ongoing thrombosis and the other because of being 
too young. Of the included patients, three sustained a re-rupture during the initial 
study and were also withdrawn from the one-year follow-up. 
Eight patients ceased to participate and dropped out before two week follow-up (Fig. 
1), owing either to unwillingness to continue with the research project (n = 4), 
violations of the research protocol (n = 2) or difficulty in tolerating the IPC device (n = 
2). Twenty-six patients did not attend their scheduled appointment to the one-year 
follow-up control. Hence a total number of 111 patients were analyzed after the one-
year follow-up and functional evaluation (Figure 1).  
All eligible subjects received standardized verbal and written information about the 
trial, and gave written informed consent to participate in the study.  The study was 
conducted with approval by the Regional Ethical Review Committee in Stockholm, 
Sweden. 
 
Treatment protocol  
The surgical procedure and treatment protocol is described elsewhere (11). After 
completion of surgery study patients were randomized to receive either conventional 
post-operative plaster cast immobilization or adjuvant intermittent pneumatic 
compression in an orthosis during the first two post-operative weeks. At two weeks 
all patients returned for follow-up with assessment of DVT. After the two weeks visit 
all patients were mobilised with an orthosis (Don-Joy Walker; DJO, Vista, California) 
and were instructed to start full weight-bearing. At the six weeks visit the brace was 
removed. 
 
Assessment of deep venous thrombosis (DVT)  
All patients were screened for DVT in the operated leg by unilateral color duplex 
sonography (CDS) at 2 weeks post operatively, described in detail in previous report 
(11). Two experienced ultrasonographists, blinded to the treatment regimens, 
performed all the screening for DVTs using a Philips CX 50 (Philips Medical 
Systems, Andover, MA, USA). The standard procedure included evaluation of all 
deep proximal and distal veins, including muscle veins. Proximal DVT was defined as 
a thrombosis that involved the popliteal vein or any more proximal veins, with or 
without involvement of the calf veins. The diagnostic procedure and the criteria for 
DVT diagnosis have been described in detail elsewhere (12, 13). Briefly, the DVT 
diagnosis was based on a transversal ultrasound compression test of the blood 
vessel, and assessment of blood flow in the veins by color Doppler flow. Data 
collection on symptomatic and asymptomatic DVTs was performed but due to 
uncertain data quality statistical analysis was not possible. The study protocol stated 
that the patients with diagnosed DVTs should receive LMWH, dalteparine, in 
therapeutic dose based on the patient’s weight, and according to the protocol of the 
coagulation unit of our hospital. Hence, patients with a diagnosed DVT received 
subcutaneous injection of dalteparine (Fragmin®, Pfizer) 15 000 U or 18 000 U once 
daily for 8-12 weeks. 
 
Patient-reported outcome and physical activity  
The patients’ symptoms and physical activity levels were assessed using four reliable 
and valid scores; the Achilles tendon Total Rupture Score (ATRS) (14) Physical 
Activity scale (PAS) (15) Foot and Ankle Outcome Score (FAOS)(16) and EuroQol 
Group’s questionnaire (EQ-5D) (17). The ATRS ranges from 0 to 100; a lower score 
indicates more symptoms and greater limitation of physical activity. For the PAS, a 
score of 1 equals no physical activity, whereas a score of 6 equals heavy physical 
exercise several times per week.  An EQ-5D score of 0 is considered to be the worst 
imaginable health state and a score of 1.00 the best imaginable health state.  
 
Functional evaluation 
One year after injury all patients returned for assessment of functional outcome. The 
functional evaluation consisted of muscular endurance tests and was performed as 
previously described in the literature (18, 19)(Figure 2). The tests have been shown 
to be reliable and valid (20, 21) and have frequently been used in evaluating outcome 
after Achilles tendon rupture (3, 6, 19, 22, 23). All evaluations were performed by two 
independent physical therapists. The patients’ height and weight were measured and 
documented. The tests were always performed in the same order, and the uninjured 
side was always tested first. All subjects were given standardized instructions and 
the tests were demonstrated by the examiner. Verbal encouragement was used and 
athletic footwear was standardized. Prior to testing, the patients warmed up on a 
stationary bicycle for 5 min followed by one set of 10 two-legged heel-rises. 
MuscleLab (Ergotest Technology, Oslo, Norway) measurement system was used for 
the evaluations.  
The heel-rise test for endurance was performed on one leg at a time with the 
participant standing on a box with an incline of 10 degrees. The participants were 
allowed to place the fingertips, at shoulder height, against the wall, for balance. A 
metronome was used to keep a heel-rise frequency of 30 per minute. The participant 
was instructed to go as high as possible on each heel-rise and then lower the heel to 
the starting position, and to perform as many heel-rises as possible. The test was 
terminated when the patient stopped, could not maintain the frequency, or did not 
perform a proper heel-rise. The numbers of heel-rises, the time and height of each 
heel-rise, the total work (the body weight x total distance) in joules and the power 
(work / time) were used for data analysis.  
 
Achilles Combined Outcome Score (ACOS) 
In order to obtain one uniform outcome score for ATR patients, three validated 
outcome measures were combined to yield the Achilles Combined Outcome Score 
(ACOS). Based on previous studies (7, 24, 25), indirect tendon length (Heel-rise 
height and Limb Symmetry Index-height) and ATRS are the most validated 
variables/methods for assessment of tendon function. The correlations between 
these three outcome measures were very weak, i.e. below 0.30 (the highest 
correlation was found between maximum heel rise and the symmetry index (τ= 0.28, 
p= 0.001) indicating that they are independent measures of the outcome. 
The uniform outcome measure, ACOS, was therefore established from the three 
variables ATRS, maximum height of heel-rise (injured side), and limb symmetry index 
(height). These three measures were first dichotomized at the median value. If the 
value was above the median, the patient received a score of 1.0, or below a zero 
value. The three values were then added to a total unweighted score that ranged 
from 0 (minimum outcome) to 3 (maximum outcome). Fifteen (14 %) patients 
received a total score of zero, 37 (33 %) patients a total score of 1.0, 36 (32 %) 
patients a total score of 2.0, and 23 (21 %) patients a total score of 3.0. This outcome 
score was, finally, dichotomized according to the median (2.0).  
 
Demographic and clinical data 
Several variables were documented for each patient, including age, gender, Body 
Mass Index (BMI) smoking habits, and the duration of daily intermittent pneumatic 
compression. 
 
Statistical analysis  
The descriptive statistics and statistical analyses were conducted with SPSS, version 
22.0. All variables were summarized with standard descriptive statistics such as 
frequencies, means and standard deviations. The Limb symmetry index (LSI) was 
defined as the ratio between the involved limb and the uninvolved limb expressed as 
a percentage (involved/uninvolved x 100 = LSI). Provided that the distribution of a 
variable was not severely skewed differences between groups were analyzed with 
oneway analysis of variance (ANOVA) or Student’s t-test (for two-groups 
comparisons). If a variable was severely skewed, i.e. the skewness statistics was 
greater than 1.5, Mann-Whitney U test was applied for the two-groups comparison. 
The significance level in all analyses was 5 percent (two-tailed). 
The dichotomized outcome measure, ACOS, was entered into a logistic regression 
analysis (stepwise forward with an inclusion level of 5 %) as the dependent variable 
with six independent variables or predictors: gender (man= 1 and woman= 2) age 
(age≤ 40 was set to 0, and age> 40 to 1) smoker (nonsmoker= 0, and current 
smoker= 1) BMI (BMI≤ 26.0 was set to 0, and BMI> 26.0 to 1) DVT (no DVT= 0, and 
a DVT= 1) and, finally, pre-injury level of activity (exercise up to 1-2 hours/week= 0, 
and above= 1). For age, BMI, and pre-injury level of activity the median was used as 
an unbiased cut-off. The relationships between the dependent and independent 
variables were expressed as odds ratios (OR) with 95 percent confidence intervals 
(C.I.). Since the regression analysis was a stepwise forward, only significant 




Multiple Linear Regression Analysis 
A multiple logistic regression analysis was performed based on the dichotomized 
ACOS (dACOS) assigned 1, good outcome (n=59) or 0, poor outcome (n=50) 
(please see materials and methods for a description of ACOS). The analysis 
examined the unique contribution of: age, gender, BMI, treatment, smoking, physical 
activity score (PAS) as well as deep venous thrombosis (DVT).  
The multiple logistic regression analysis demonstrated that three independent 
variables correlated significantly and independently with dACOS at one year; age, 
gender and deep venous thrombosis after two weeks. Thus, higher age, age ≥40 
years, was the strongest independent predictor of developing a poor outcome 
(dACOS=1) at one year after ATR (Table 2). Male gender was the second most 
important factor for obtaining a poor outcome. Notably, exhibiting a DVT during the 
post-operative immobilization was also an important independent predictor for a poor 
outcome after ATR (dACOS=0). BMI, PAS treatment and smoking did not 
significantly predict the outcome after ATR as assessed with dACOS. 
 
Age 
The strongest predictor of functional outcome and symptoms at one year was age. 
Patients aged over 40 years demonstrated a LSI of total concentric work of 58% 
compared to patients aged below 40 that reached 71% (p<0.001). Maximum heel-
rise height was 9.73 cm in the older patient group and 11.51 cm in the younger 
patients (p<0.001). PAS differed significantly between the two age groups before 
injury (p=0.047), while the difference was not significant after injury (p=0.157). BMI 
as well as patient-reported outcome, ATRS and EQ-5D, however, did not differ 
between the two age groups (Table 3). 
 
DVT 
Patients experiencing a DVT postoperatively exhibited a significantly lower maximum 
heel-rise height of 9.89 cm as compared to patients without a DVT that reached 
11.14 cm (p=0.018). LSI of heel-rise height was significantly different between 
patients without (84%) and patients with a DVT (75%) (p=0.008). LSI of total 
concentric work did not reach the recommended levels of 85% in the DVT group 
(61%), nor the non-DVT group (67%), and the difference between the groups was not 
significant (p= 0.164). ATRS was lower in the DVT group (73.21) than in the healthy 
group (79.16), but the difference did not reach significance (p=0.131) (Table 4).  
In the recently published RCT the effect of receiving IPC beneath orthosis compared 
to standard plaster cast following ATR was assessed (26). Screening with CDU at 
two weeks post-operatively demonstrated a DVT in 23% of patients (n = 16/69) in the 
ITT analysis and 21 % of patients (n = 14/67) in the PP analysis in the IPC group and 
in 37% of patients (n = 26/71) in the control group. The patients who were compliant 
with the IPC-treatment exhibited a significant reduction in the risk of DVT, after 
correction for age differences between groups (ITT analysis: OR = 2.11; 95% CI 0.97 
to 4.62; p = 0.061 and PP analysis: OR = 2.60; 95% CI 1.15 to 5.91; p = 0.022). 
Patients with a diagnosed DVT received subcutaneous injection of dalteparine 
(Fragmin®, Pfizer) 15 000 U or 18 000 U once daily for 8-12 weeks. No adverse 
events related to the treatment were observed. 
 
Gender  
Male gender exhibited a tendency towards lower LSI of concentric power 81% 
compared to women who reached 91% (p=0.099). Maximum heel-rise height was 
10.6 cm among men and 11.5 cm among women (p=0.251). However, since the BMI 
in men was higher than in women (27 versus 24) (p<0.001) the LSI of total concentric 
work (65% versus 71%) did not differ significantly (p=0.265). Interestingly, the 
difference in PAS between men and women (3.67 vs. 4.27) was larger post injury 
(16%) compared to preinjury (7%) (4.56 vs. 4.87) (Table 5). 
 
Age, DVT and Gender Combined 
Formatted: English (US)
To illustrate the difference in outcome of patients with combined good predictors 
versus patients with combined bad predictors, we extracted these two groups from 
the cohort (Table 6). Being a female aged less than 40 years and without 
experiencing a DVT during post-operative immobilization resulted in almost 50% 
better heel-rise height (p=0.009) and around 40% better LSI of height (p=0.004) as 
well as LSI of concentric power (p=0.027) compared to males over 40, who 
experienced a DVT.  
 
Discussion 
This study established three critical independent predictors of clinical outcome after 
acute Achilles tendon rupture; age, gender and DVT. The data herein corroborate 
age and sex as predictors for all ATR-patients, but also highlight a novel and possibly 
preventable factor for poor outcome, i.e. DVT.  
 
Our findings of increasing age and male gender being independent negative 
predictors of outcome after ATR confirm the hypothesis of two earlier studies in this 
area (6, 22). Moreover, this patient cohort also included female patients, which were 
not included in one earlier study (6). 
 
This study also included new and preventable factors such as DVT and smoking into 
the analysis of predictors. DVT incidence in ATR patients has recently been found 
very high, 36-50% as assessed with Doppler ultrasound, irrespective of operation or 
conservative treatment (8-10). Thus, the demonstrated independent negative 
predictive value of exhibiting a DVT suggests that measures of preventing the 
development of DVT may improve outcome after ATR.  
Pharmacological DVT prophylaxis, however, has been demonstrated non-effective 
for preventing the development of DVT after ATR (8), possibly because of deficient 
blood flow in the immobilized leg. Conceivably, DVT prophylaxis, i.e. low molecular 
weight heparin (LMWH), may even be deleterious for tendon healing. Thus, earlier 
experimental studies on rat Achilles tendon repair during continuous administration of 
LMWH demonstrated impairment of tendon healing (28). In this study patients 
diagnosed with DVT received treatment with LMWH, dalteparine, in therapeutic dose, 
which theoretically may have affected the outcome. Whether dalteparin administrated 
once daily in patients can affect the outcome after ATR is yet unknown. However, all 
these facts urge the establishment of alternative DVT-preventive measures, eg. 
mechanical DVT prophylaxis.  
 
Another option to address the venous stasis during immobilization would be to use 
mechanical DVT prophylaxis applying intermittent pneumatic compression (IPC), an 
effective method of reducing the DVT rate during leg immobilization after ATR 
without any negative side effects (11). IPC has also been proven effective in an 
outpatient setting. 
 
The observed link between DVT and impaired outcome may also be due to a 
decreased arterial blood flow during immobilization. Mechanical compression may 
target this problem by increasing venous return, which in turn improves arterial flow 
(27). IPC can furthermore by cyclical tissue shear stress induce the production of 
chemical substances: antithrombotic and pro-fibrinolytic substances as well as 
substances that are known to enhance tissue repair (12, 21, 22). However, there is 
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still a need of more direct proof that mechanical compression therapy can increase 
the functional outcome after ATR.   
 
The negative outcome associated with aging may be related to intrinsic or extrinsic 
factors, independent of the higher risk of DVT associated with aging. Intrinsic 
changes of aging may be related to reductions in tendon stiffness and resistance to 
loads (29), as well as metabolic interactions in tendon collagen production. Thus, 
high glucose (glycation) and diabetes can impair and lead to defective Achilles 
tendon healing (30, 31).  
We noted in our study that patients aged over 40 exhibited reduced heel-rise height, 
repetitions and total work as compared to patients below 40. Thus, extrinsic 
alterations of aging may be related to decreased physical activity and less 
mobilization post-injury, which presumably could be counteracted by specific 
interventions (32). Specific rehabilitative interventions should be scientifically tested, 
specifically for the older ATR patients. 
The gender differences found in ATR patients are intriguing, i.e. that male patients 
experience worse outcome. These results are consistent with data presented by 
Bostick et al (22), but differ from the results shown by Olsson et al (7). Such 
differences between cohorts may be due to dissimilarities in patient characteristics as 
well as physical rehabilitation.  
One variable differing between genders was a higher BMI in male patients, 
suggesting that the male patients were overweight and thereby maybe also 
undertook less early mobilization. Our data at one year post-operatively indicated a 
tendency towards that female patients were more physically active than males. 
These parameters may be important underlying factors affecting gender differences.  
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In fact, the study by Olsson et al. supports our hypothesis that BMI and physical 
activity may influence gender differences. Thus, they found that male patients with 
higher BMI exhibited worse patient-reported outcome but no major effect on function. 
Higher preoperative physical activity level was associated with worse patient-
reported outcome, but had a small positive influence on functional outcome.  
In a cohort study by Silbernagel et al., female patients had a greater degree of deficit 
in heel-rise height as compared to males, irrespective of surgical- or non-surgical 
treatment (33). Since female ATR patients are <20% of all ATR patients, larger 
randomized clinical trials are needed to conclude on the associations between 
gender and outcome.  
 
The observed reduction of functional outcome was not paralleled with the same 
extent of reduced patient-reported outcome as assessed by the ATRS questionnaire. 
This discrepancy is partly assumed to be an adaptation to the injury (2, 5). We 
therefore believe that the combination of the outcomes in a uniform score, Achilles 
Combined Outcome Score (ACOS), as used in this study, gives a broader view of the 
patient status at one year post Achilles tendon rupture.   
 
Conclusion 
This study provides predictors, which will lead the way towards a more individualized 
and evidence-based clinical decision-making of ATR patients. DVT during leg 
immobilization, aging and male gender are independent, negative predictive factors 
for outcome of patients at one-year post Achilles tendon rupture. This is the first 
manuscript to demonstrate that patients, who sustain a DVT post Achilles tendon 
rupture, exhibit impaired both patient-reported and functional outcome. The results 
Deleted: 1 
Deleted: one year
from this study suggest that patients should be informed about predictive risk factors. 
Further studies should address risk factors in a targeted manner, eg. by 
individualized treatment protocols with focus on early weight bearing and mechanical 
thromboprophylaxis, to improve outcome after Achilles tendon rupture.  
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Table 1. Patient Demographics 
 
Variable (n = 111) 
Age ± SD 40.8±9.0 
Gender (%)  
   Male 95 (87) 
   Female 15 (13) 
Smoker (%) 3/111 (3) 
Post-operative Treatment (%)  
   Orthosis with IPC 52 (47) 
   Plaster cast 59 (53) 
Deep Venous Thrombosis  (%) 34/111 (31) 
Body Mass Index ± SD 26.8 ±3.3 
Time to Surgery (h) ± SD 54.5 ±30.8 
Time in Surgery (min) ± SD 35 ±11 
 




Table 2. Relationship between gender, age, deep venous thrombosis, and outcome 
       95% C. I.1 for OR2 
Independent variable B S.E. df p OR2 Lower Upper 
Gender (Man= 1; Woman= 2) 1.43 0.724 1 0.048 4.18 1.01 17.24 
Age (40 or less= 0; above 40= 1) -1.59 0.462 1 0.001 0.20 0.08 0.51 
Deep venous thrombosis after 
two weeks? (No= 0, Yes= 1) -1.19 0.491 1 0.016 0.31 0.12 0.80 
Constant -0.36 0.784        
 
1 C.I. = Confidence Interval 
















Table 3. Outcome at one year post-operatively treated Achilles tendon rupture in 






≤ 40 (n=63) > 40 (n=48) 
  Mean SD Mean SD p-value 
% 
Difference 
Heel-rise concentric work (LSI) 71% 17.2  58% 22.4 <0.001  22% 
Heel-rise height injured side (cm) 11,51 2.2  9,73 2.6 <0.001 18% 
Heel-rise height (LSI) 86% 14.3  74% 14.9 <0.001  16% 
Heel-rise concentric power (LSI) 87% 19.0  76% 22.6 0.006 14% 
PAS postinjury 3.90 1.2 3.56 1.2 0.157 10% 
Heel-rise Repetitions (LSI) 84% 18.1 77% 19.9 0.061 9% 
PAS preinjury 4.75 0.9 4.43 0.8 0.047 7% 
ATRS  77,55 19.0 77,02 18.9 0.885 1% 
BMI 26.9 3.5 26.6 2.9 0.570 1% 
EQ-5D 0.917 0.11 0.911 0.10 0.772 1% 
 
LSI=Limb symmetry index; PAS=Physical Activity Scale; ATRS=Achilles tendon Total 
Rupture Score; EQ-5D=EuroQol Group’s questionnaire; BMI=Body Mass Index; 
SD=Standard deviation; n=number of patients.  
 
Table 4. Outcome at one year post-operatively treated Achilles tendon rupture in 





No (n=77) Yes (n=34) 
  Mean SD Mean SD p-value 
% 
Difference 
Heel-rise height injured side 
(cm) 11.14 2.4 9.89 2.7 0.018 13% 
Heel-rise height (LSI) 84% 15.3 75% 15.2 0.008 12% 
Heel-rise concentric work 
(LSI) 67% 17.6 61% 25.6 0.164 10% 
ATRS 79.16 18.7 73.21 18.9 0.131 8% 
PAS postinjury 3.84 1 3.58 1.1 0.32 7% 
Heel-rise concentric power 
(LSI) 82% 19.7 78% 24.1 0.105 5% 
Heel-rise repetitions (LSI) 82% 17.7 78% 22.1 0.356 5% 
EQ-5D 0.918 0.1 0.906 0.1 0.604 1% 
BMI 26.8 3.4 26.6 2.9 0.778 1% 
PAS preinjury 4.6 0.9 4.63 0.8 0.877 -1% 
LSI=Limb symmetry index; PAS=Physical Activity Scale; ATRS=Achilles tendon Total 
Rupture Score; EQ-5D=EuroQol Group’s questionnaire; BMI=Body Mass Index; 
SD=Standard deviation; n=number of patients.  
Table 5. Outcome at one year post-operatively treated Achilles tendon rupture in 






Female (n=15) Male (n=96) 





PAS postinjury 4.27 1 3.67 1.3 0.085 16% 
Heel-rise concentric power (LSI) 91% 30% 81% 20% 0.099 12% 
Heel-rise concentric work (LSI) 71%. 27% 65%. 19% 0.298 9% 
Heel-rise height injured side (cm) 11.46 3.04 10.64 2.49 0.251 8% 
PAS preinjury 4.87 0.8 4.56 0.8 0.195 7% 
Heel-rise height (LSI) 84% 16% 81% 16% 0.402 4% 
ATRS 79.2 16.28 77.02 19.33 0.68 3% 
Heel-rise repetitions (LSI) 81% 20% 81% 19% 0.988 0% 
EQ-5D 0.867 0.1 0.922 0.1 0.063 -6% 
BMI 23.8 2.9 27.2 3.1 <0.001 -13% 
LSI=Limb symmetry index; PAS=Physical Activity Scale; ATRS=Achilles tendon Total 
Rupture Score; EQ-5D=EuroQol Group’s questionnaire; BMI=Body Mass Index; 
SD=Standard deviation; n=number of patients.  
 
Table 6. Outcome at one year post-operatively treated Achilles tendon rupture in 
patients with or without predicting factors of poor outcome.  





  Mean SD Mean SD p-value 
% 
Difference 
Heel-rise height injured side (cm) 13.1 3.1 8.9 3.0 0.009 47% 
PAS postinjury 4.3 1.0 3.1 1.1 0.025 39% 
Heel-rise concentric power (LSI) 96% 24% 70% 22% 0.027 37% 
Heel-rise concentric work (LSI) 74% 19% 54% 23% 0.071 37% 
Heel-rise height (LSI) 96% 14% 71% 16% 0.004 35% 
PAS preinjury 5.2 0.8 4.4 0.6 0.023 18% 
Heel-rise repetitions (LSI) 85% 22% 76% 25% 0.457 12% 
ATRS 75.3 18.4 71.0 21.1 0.666 6% 
EQ-5D 0.853 0.1 0.901 0.1 0.393 -5% 
BMI 21.7 1.5 26.8 3.0 0.001 -19% 
LSI=Limb symmetry index; PAS=Physical Activity Scale; ATRS=Achilles tendon Total 
Rupture Score; EQ-5D=EuroQol Group’s questionnaire; BMI=Body Mass Index; 
SD=Standard deviation; n=number of patients.  		
